Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet a radiation (PUVA)

New England Journal of Medicine

Volumn 336, Issue 15, 1997, Pages 1041-1045

  Stern, Robert S ^a,b   Nichols, Khanh T ^a   Väkevä, Liisa H ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXSALEN;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MALE; MELANOMA; PRIORITY JOURNAL; PSORIASIS; PUVA; RISK ASSESSMENT;

ADULT; AGED; FEMALE; HUMANS; MALE; MELANOMA; METHOXSALEN; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; PSORIASIS; PUVA THERAPY; REGRESSION ANALYSIS; RISK; RISK FACTORS; SKIN NEOPLASMS; TIME FACTORS;

EID: 0030896996     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199704103361501     Document Type: Article

References (30)

1. Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med 1974;291:1207-11.
2. Stern RS, Laird N, Melski J, Parrish JA, Fitzpatrick TB, Bleich HL. Cutaneous squamous-cell carcinoma in patients treated with PUVA. N Engl J Med 1984;310:1156-61.
3. Stern RS, Members of the Photochemotherapy Follow-up Study. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. N Engl J Med 1990;322: 1093-7.
4. Stern RS, Laird N. The carcinogenic risk of treatments for severe psoriasis: Photochemotherapy Follow-up Study. Cancer 1994;73:2759-64.
5. Rhodes AR, Stern RS, Melski JW. The PUVA lentigo: an analysis of predisposing factors. J Invest Dermatol 1983;81:459-63.
6. Cox NH, Jones SK, Downey DJ, et al. Cutaneous and ocular side-effects of oral photochemotherapy: results of an 8-year follow-up study. Br J Dermatol 1987;116:145-52.
7. Rhodes AR, Harrist TJ, Momtaz-T K. The PUVA-induced pigmented macule: a lentiginous proliferation of large, sometimes cytologically atypical, melanocytes. J Am Acad Dermatol 1983;9:47-58.
8. Abel EA, Reid H, Wood C, Hu CH. PUVA-induced melanocytic atypia: is it confined to PUVA lentigines? J Am Acad Dermatol 1985;13:761-8.
9. Alcalay J, Bucana C, Kripke ML. Cutaneous pigmented melanocytic tumor in a mouse treated with psoralen plus ultraviolet A radiation. Photodermatol Photoimmunol Photomed 1990;7:28-31.
10. Aubin F, Donawho CK, Kripke ML. Effect of psoralen plus ultraviolet A radiation on in vivo growth of melanoma cells. Cancer Res 1991;51: 5893-7.
11. Setlow RB, Grist E, Thompson K, Woodhead AD. Wavelengths effective in induction of malignant melanoma. Proc Natl Acad Sci U S A 1993; 90:6666-70.
12. White E, Kirkpatrick CS, Lee JAH. Case-control study of malignant melanoma in Washington State. I. Constitutional factors and sun exposure. Am J Epidemiol 1994;139:857-68.
13. Elwood JM, Gallagher RP, Worth AJ, Wood WS, Pearson JCG. Etiological differences between subtypes of cutaneous malignant melanoma: Western Canada Melanoma Study. J Natl Cancer Inst 1987;78:37-44.
14. Graham S, Marshall J, Haughey B, et al. An inquiry into the epidemiology of melanoma. Am J Epidemiol 1985;122:606-19.
15. Cancer Statistics Branch. Surveillance, Epidemiology, and End Results (SEER) program public use: CD-ROM (1973-92). Bethesda, Md.: National Cancer Institute, 1995 (software).
16. Gahlinger PM, Abramson JH. Computer programs for epidemiologic analysis. Honolulu: Makapuu Medical Press, 1993.
17. STATA reference manual, version 5. College Station, Tex.: Stata Press, 1997.
18. MacDonald KJ, Hargreaves GK, Ead RD. Longitudinal melanonychia during photochemotherapy. Br J Dermatol 1986;114:395-6.
19. Kemmett D, Reshad H, Baker H. Nodular malignant melanoma and multiple squamous cell carcinomas in a patient treated by photochemotherapy for psoriasis. BMJ 1984;289:1498.
20. Frenk E. Malignant melanoma in a patient with severe psoriasis treated by oral methoxsalen photochemotherapy. Dermatologica 1983;167: 152-4.
21. Binet O, Bruley C, Beltzer-Garelly E, Cesarini JP. Mélanome malin après traitement par rayons ultra-violets A et psoralène. Presse Med 1985; 14:1842.
22. Bergner T, Przybilla B. Malignant melanoma in association with phototherapy. Dermatology 1992;184:59-61.
23. Gupta AK, Stern RS, Swanson NA, Anderson TF. Cutaneous melanomas in patients treated with psoralens plus ultraviolet A: a case report and the experience of the PUVA Follow-up Study. J Am Acad Dermatol 1988; 19:67-76.
24. Henseler T, Christophers E, Hönigsmann H, Wolff K. Skin tumors in the European PUVA Study: eight-year follow-up of 1,643 patients treated with PUVA for psoriasis. J Am Acad Dermatol 1987;16:108-16.
25. Lindelöf B, Sigurgeirsson B, Tegner E, et al. PUVA and cancer: a large-scale epidemiological study. Lancet 1991;338:91-3.
26. Heenan PJ, Matz LR, Blackwell JB, et al. Inter-observer variation between pathologists in the classification of cutaneous malignant melanoma in western Australia. Histopathology 1984;8:717-29.
27. Krieger N, Hiatt RA, Sagebiel RW, Clark WH Jr, Mihm MC Jr. Inter-observer variability among pathologists' evaluation of malignant melanoma: effects upon an analytic study. J Clin Epidemiol 1994;47: 897-902.
28. Corona R, Mele A, Amini M, et al. Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J Clin Oncol 1996;14:1218-23.
29. Moseley HS, Giuliano AE, Storm FK III, Clark WH, Robinson DS, Morton DL. Multiple primary melanoma. Cancer 1979;43:939-44.
30. Koh HK. Cutaneous melanoma. N Engl J Med 1991;325:171-82.